Search Results 101-110 of 23139 for B cell lymphomas

  1. Study of Brentuximab Vedotin Combined With RCHOP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    Study of Brentuximab Vedotin Combined With RCHOP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) · Overview · Participation ...

  2. Follicular Lymphoma Clinical Trials - Mayo Clinic Research

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with follicular lymphoma. Venetoclax ...

  3. LymphoStats - Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Mayo Clinic Research

    These models and tools have been developed by the lab or in collaboration with lab members. Prognostic models. Diffuse large B-cell lymphoma. Newly diagnosed.

  4. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... B-Cell Non-Hodgkin Lymphomas. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  5. A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-cell non-Hodgkin lymphoma (NHL) subtypes of diffuse large B-cell lymphoma (DLBCL) and Grade 3 follicular lymphoma (FL3). Additionally, the pharmacokinetic ...

  6. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma · Share · Facebook · Twitter.

  7. Anne J. Novak, Ph.D. - Mayo Clinic Faculty Profiles

    B-cell lymphomas are a heterogeneous group of neoplasms that arise from lymphocytes and produce tumors in the lymph nodes, lymphatic organs and extranodal ...

  8. Targeted Drug with Chemotherapy Combo Offers Longer Life to Patients with B-cell Cancers - Mayo Clinic News Network

    ... cell lymphoma, a subset of B-cell lymphoma. It was also approved in February 2014 for use in CLL, following a study of the agent alone in patients with very ...

  9. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia ...

  10. A Study to Evaluate the Safety and Effectiveness of ALLO-501A CAR T Cell Therapy in Adults with Relapsed/ Refractory Large B Cell Lymphoma - Mayo Clinic

    The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...